Literature DB >> 23897612

CD8+ T cells specific for a malaria cytoplasmic antigen form clusters around infected hepatocytes and are protective at the liver stage of infection.

Kazumi Kimura1, Daisuke Kimura, Yoshifumi Matsushima, Mana Miyakoda, Kiri Honma, Masao Yuda, Katsuyuki Yui.   

Abstract

Following Anopheles mosquito-mediated introduction into a human host, Plasmodium parasites infect hepatocytes and undergo intensive replication. Accumulating evidence indicates that CD8(+) T cells induced by immunization with attenuated Plasmodium sporozoites can confer sterile immunity at the liver stage of infection; however, the mechanisms underlying this protection are not clearly understood. To address this, we generated recombinant Plasmodium berghei ANKA expressing a fusion protein of an ovalbumin epitope and green fluorescent protein in the cytoplasm of the parasite. We have shown that the ovalbumin epitope is presented by infected liver cells in a manner dependent on a transporter associated with antigen processing and becomes a target of specific CD8(+) T cells from the T cell receptor transgenic mouse line OT-I, leading to protection at the liver stage of Plasmodium infection. We visualized the interaction between OT-I cells and infected hepatocytes by intravital imaging using two-photon microscopy. OT-I cells formed clusters around infected hepatocytes, leading to the elimination of the intrahepatic parasites and subsequent formation of large clusters of OT-I cells in the liver. Gamma interferon expressed in CD8(+) T cells was dispensable for this protective response. Additionally, we found that polyclonal ovalbumin-specific memory CD8(+) T cells induced by de novo immunization were able to confer sterile protection, although the threshold frequency of the protection was relatively high. These studies revealed a novel mechanism of specific CD8(+) T cell-mediated protective immunity and demonstrated that proteins expressed in the cytoplasm of Plasmodium parasites can become targets of specific CD8(+) T cells during liver-stage infection.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23897612      PMCID: PMC3811763          DOI: 10.1128/IAI.00570-13

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  50 in total

1.  Mycobacterial infection of macrophages results in membrane-permeable phagosomes.

Authors:  R Teitelbaum; M Cammer; M L Maitland; N E Freitag; J Condeelis; B R Bloom
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

2.  Defective TCR expression in transgenic mice constructed using cDNA-based alpha- and beta-chain genes under the control of heterologous regulatory elements.

Authors:  M J Barnden; J Allison; W R Heath; F R Carbone
Journal:  Immunol Cell Biol       Date:  1998-02       Impact factor: 5.126

3.  Elimination of P. berghei liver stages is independent of Fas (CD95/Apo-I) or perforin-mediated cytotoxicity.

Authors:  J Renggli; M Hahne; H Matile; B Betschart; J Tschopp; G Corradin
Journal:  Parasite Immunol       Date:  1997-03       Impact factor: 2.280

4.  Release of malaria circumsporozoite protein into the host cell cytoplasm and interaction with ribosomes.

Authors:  F U Hügel; G Pradel; U Frevert
Journal:  Mol Biochem Parasitol       Date:  1996-10-30       Impact factor: 1.759

5.  Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria.

Authors:  P Romero; J L Maryanski; G Corradin; R S Nussenzweig; V Nussenzweig; F Zavala
Journal:  Nature       Date:  1989-09-28       Impact factor: 49.962

6.  Genetically modified Plasmodium parasites as a protective experimental malaria vaccine.

Authors:  Ann-Kristin Mueller; Mehdi Labaied; Stefan H I Kappe; Kai Matuschewski
Journal:  Nature       Date:  2004-12-05       Impact factor: 49.962

7.  Genetic control of immunity to Plasmodium yoelii sporozoites.

Authors:  W R Weiss; M F Good; M R Hollingdale; L H Miller; J A Berzofsky
Journal:  J Immunol       Date:  1989-12-15       Impact factor: 5.422

8.  In vivo imaging of CD8+ T cell-mediated elimination of malaria liver stages.

Authors:  Ian A Cockburn; Rogerio Amino; Reka K Kelemen; Scot C Kuo; Sze-Wah Tse; Andrea Radtke; Laura Mac-Daniel; Vitaly V Ganusov; Fidel Zavala; Robert Ménard
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-14       Impact factor: 11.205

Review 9.  Antigens for pre-erythrocytic malaria vaccines: building on success.

Authors:  C Speake; P E Duffy
Journal:  Parasite Immunol       Date:  2009-09       Impact factor: 2.280

10.  Dendritic cells and hepatocytes use distinct pathways to process protective antigen from plasmodium in vivo.

Authors:  Ian A Cockburn; Sze-Wah Tse; Andrea J Radtke; Prakash Srinivasan; Yun-Chi Chen; Photini Sinnis; Fidel Zavala
Journal:  PLoS Pathog       Date:  2011-03-17       Impact factor: 6.823

View more
  23 in total

Review 1.  Advances in molecular genetic systems in malaria.

Authors:  Tania F de Koning-Ward; Paul R Gilson; Brendan S Crabb
Journal:  Nat Rev Microbiol       Date:  2015-06       Impact factor: 60.633

2.  Nonspecific CD8+ T Cells and Dendritic Cells/Macrophages Participate in Formation of CD8+ T Cell-Mediated Clusters against Malaria Liver-Stage Infection.

Authors:  Masoud Akbari; Kazumi Kimura; Ganchimeg Bayarsaikhan; Daisuke Kimura; Mana Miyakoda; Smriti Juriasingani; Masao Yuda; Rogerio Amino; Katsuyuki Yui
Journal:  Infect Immun       Date:  2018-03-22       Impact factor: 3.441

3.  Mathematical Modeling to Guide Experimental Design: T Cell Clustering as a Case Study.

Authors:  Harshana Rajakaruna; Vitaly V Ganusov
Journal:  Bull Math Biol       Date:  2022-08-17       Impact factor: 3.871

4.  Interactions with Asialo-Glycoprotein Receptors and Platelets Are Dispensable for CD8+ T Cell Localization in the Murine Liver.

Authors:  James H O'Connor; Hayley A McNamara; Yeping Cai; Lucy A Coupland; Elizabeth E Gardiner; Christopher R Parish; Brendan J McMorran; Vitaly V Ganusov; Ian A Cockburn
Journal:  J Immunol       Date:  2022-06-01       Impact factor: 5.426

5.  CD8+ T cells eliminate liver-stage Plasmodium berghei parasites without detectable bystander effect.

Authors:  Ian A Cockburn; Sze-Wah Tse; Fidel Zavala
Journal:  Infect Immun       Date:  2014-01-13       Impact factor: 3.441

Review 6.  T cell-mediated immunity to malaria.

Authors:  Noah S Butler; John T Harty; Samarchith P Kurup
Journal:  Nat Rev Immunol       Date:  2019-07       Impact factor: 53.106

7.  The subcellular location of ovalbumin in Plasmodium berghei blood stages influences the magnitude of T-cell responses.

Authors:  Jing-Wen Lin; Tovah N Shaw; Takeshi Annoura; Aurélie Fougère; Pascale Bouchier; Séverine Chevalley-Maurel; Hans Kroeze; Blandine Franke-Fayard; Chris J Janse; Kevin N Couper; Shahid M Khan
Journal:  Infect Immun       Date:  2014-08-25       Impact factor: 3.441

8.  Antigen-driven focal inflammatory death of malaria liver stages.

Authors:  Ganchimeg Bayarsaikhan; Masoud Akbari; Katsuyuki Yui; Rogerio Amino
Journal:  Front Microbiol       Date:  2015-02-04       Impact factor: 5.640

9.  Cytotoxic activities of CD8⁺ T cells collaborate with macrophages to protect against blood-stage murine malaria.

Authors:  Takashi Imai; Hidekazu Ishida; Kazutomo Suzue; Tomoyo Taniguchi; Hiroko Okada; Chikako Shimokawa; Hajime Hisaeda
Journal:  Elife       Date:  2015-03-11       Impact factor: 8.140

Review 10.  Plasmodium cellular effector mechanisms and the hepatic microenvironment.

Authors:  Ute Frevert; Urszula Krzych
Journal:  Front Microbiol       Date:  2015-05-27       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.